Gastrointestinal Stromal Tumors Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Gastrointestinal Stromal Tumors Information Center has current, evidence-based information for you. Get the facts about gastrointestinal stromal tumors early detection, treatment, and survivorship, and stay up to date with ongoing gastrointestinal stromal tumors research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Gastrointestinal Stromal Tumors Community is the leading Social Media Application for Gastrointestinal Stromal Tumors patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
The FDA has approved Stivarga for advanced gastrointestinal stromal tumors that can’t be removed and no longer respond to treatment. Clinical Trial Participation Is Inadequate
Some populations are under-represented Three Years of Treatment with Gleevec Improves Survival in Gastrointestinal Stromal Tumors (GIST
Longer treatment may improve outcomes.
Cancer navigators offer patients with gastrointestional stromal tumors guidance as... Anemia: A Manageable Side Effect Gastrointestinal Stromal Tumors
Anemia, one of the most common side effects associated with cancer, affects over... Preparing for Surgery
You can help ensure that your surgery and recovery go smoothly and that you have...
Gastrointestinal Stromal Tumors Management
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer... Pay it Forward
Survivors become peer mentors to newly diagnosed women and offer experience, insight,...
Sarcoma Clinical Trials
AP23573-07-302 – Pivotal Trial to Determine the Efficacy and Safety of AP23573 when Administered as Maintenance Therapy to Patients with Metastatic Soft-Tissue or Bone Sarcomas
COGAEWS07B1 – A COG Study for Collecting and Banking Ewing Sarcoma Specimens
ET743-SAR-3002 – A multicenter, open-label single-arm study of YONDELIS (trabectedin) for subjects with locally advanced or metastatic soft tissue sarcoma who have relapsed or are refractory to standard of care treatment.